• Press release: Online availability of Sanofi’s half-year financial report for 2023

    Source: Nasdaq GlobeNewswire / 28 Jul 2023 06:22:14   America/Chicago

    Online availability of Sanofi’s half-year financial report for 2023

    Paris, July 28, 2023. Sanofi announces that its half-year financial report for the period ending June 30, 2023 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.

    This document may be found on the company’s corporate website: www.sanofi.com and downloaded from the “Investors” page, under the heading “Regulated Information in France”.

    About Sanofi
    We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
    Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

    Media Relations
    Sandrine Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.com
    Nicolas Obrist | + 33 6 77 21 27 55 | nicolas.obrist@sanofi.com
    Victor Rouault | + 33 6 70 93 71 40 | victor.rouault@sanofi.com

    Investor Relations
    Eva Schaefer-Jansen | + 33 7 86 80 56 39 | eva.schaefer-jansen@sanofi.com
    Arnaud Delépine | + 33 6 73 69 36 93 | arnaud.delepine@sanofi.com
    Corentine Driancourt | + 33 6 40 56 92 21 | corentine.driancourt@sanofi.com
    Felix Lauscher | + 1 908 612 7239 | felix.lauscher@sanofi.com
    Tarik Elgoutni| + 1 617 710 3587 | tarik.elgoutni@sanofi.com
    Nathalie Pham | + 33 7 85 93 30 17 | nathalie.pham@sanofi.com

    Attachment


Share on,